Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
开心的人杰
Lv6
2260 积分
2022-09-22 加入
最近求助
最近应助
互助留言
Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy
1天前
已完结
Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy
1天前
已完结
Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
2天前
已完结
Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade
2天前
求助中
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
1个月前
已完结
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
1个月前
已完结
Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy
1个月前
已完结
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages
2个月前
已完结
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
4个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
4个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了,么么哒
1天前
感谢,点赞,速度真快,帮大忙了,么么哒
1天前
感谢,速度真快,点赞,帮大忙了,么么哒
1天前
文章不对
2天前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论